|
PDK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.205900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.157000E-01 |
| Normal-vs-Stage2 |
2.682000E-03 |
| Normal-vs-Stage3 |
1.575860E-02 |
| Normal-vs-Stage4 |
1.182540E-03 |
| Stage1-vs-Stage2 |
1.319690E-02 |
| Stage1-vs-Stage3 |
8.334000E-02 |
| Stage1-vs-Stage4 |
5.575800E-03 |
| Stage2-vs-Stage3 |
4.513200E-01 |
| Stage2-vs-Stage4 |
8.272200E-01 |
| Stage3-vs-Stage4 |
3.223800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.499900E-02 |
| Normal-vs-AfricanAmerican |
3.582100E-02 |
| Normal-vs-Asian |
2.073600E-01 |
| Caucasian-vs-AfricanAmerican |
2.942400E-01 |
| Caucasian-vs-Asian |
8.967200E-01 |
| AfricanAmerican-vs-Asian |
5.647000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.142100E-02 |
| Normal-vs-Female |
7.102300E-02 |
| Male-vs-Female |
6.682400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.655800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.818500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.947800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.708000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.251900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.620000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.989200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.495800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.404200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.111040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.078200E-01 |
| Classical-VS-Follicular |
5.146500E-02 |
| Classical-VS-Other |
3.089400E-01 |
| Classical-VS-Normal |
7.820400E-02 |
| Tall-VS-Follicular |
6.575000E-01 |
| Tall-VS-Other |
3.351600E-01 |
| Tall-VS-Normal |
3.719700E-02 |
| Follicular-VS-Other |
5.577800E-01 |
| Follicular-VS-Normal |
2.857800E-03 |
| Other-VS-Normal |
4.751900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.856400E-02 |
| Normal-vs-N1 |
3.272500E-02 |
| N0-vs-N1 |
6.100800E-01 |
|
|
